DeepWise
深睿医疗
DeepWise (深势科技) is an AI for Science company that provides data, computing power, and AI infrastructure to support scientific research and development. Per a 2024 Linear Capital piece, it participated as a technology-industry investor in Deep Principle's seed round, contributing data and compute resources to assist the startup's R&D work . It also appears as a portfolio company that has received investment from BioMap and Fortune Venture Capital, and secured a strategic partnership with XtalPi as of 2023 .
However, elsewhere's corpus does not contain substantial direct coverage of DeepWise itself — most references to it appear as background in articles primarily about other companies (Deep Principle, XtalPi, BioMap). The entity cards and relations suggest it operates in the AI for Science infrastructure space, but the bundle lacks detailed information on its founding, full business scope, or leadership.
AI-generated — may contain errors, please verify.
Coverage
Steady Steps Toward Renewal, Momentum Into Waves | DTX 2025 Annual Review
Those who walk deeper into the cycle always spot the next beam of light.
Riding the Wind, Breaking Boundaries — Tides Surge in Hong Kong | Dalton Venture 2025 CEO Summit Successfully Concludes
At the intersection of technological revolution and industrial transformation, what should be the starting point for the globalization of the life sciences industry? Where should mainland Chinese healthcare innovators set their first foothold for overseas expansion? Against a backdrop of intensifying international competition and sustained policy tailwinds, is Hong Kong — a city that blends international perspective with institutional advantages — emerging as the bridge for tech ventures to reach the world?
Inside Dalton Venture's Portfolio | As Medical AI Surges, Deepwise Health Moves First on a Trillion-Yuan Emerging Market
Deepwise's development has witnessed every major milestone in China's medical AI industry.
Dalton Venture's Sun Qi: Prioritize Hard-Tech Sectors That Serve National Needs, Prioritize Solving Supply Chain Security Issues | Dalton Insights
At the "2023 China Investment Annual Conference" summit, Sun Qi shared his perspectives and experience with fellow guests on the topic of *How Much Longer Is the Window for Domestic Substitution in Medical Devices?*
The Essential GP Skillset Today: Reading Policy, Reading the Macro Trend, and Getting the Timing Right | Dalton Insight
China's past economic growth was bought with high-intensity input of production factors. The only way to break through going forward is to use technology to transform production relations and shift toward high-quality development.
